Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overlapping but Disparate Inflammatory and Immunosuppressive Responses to SARS-CoV-2 and Bacterial Sepsis: An Immunological Time Course Analysis
Tyler J. Loftus, Ricardo Ungaro, Marvin L. Dirain, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25

Showing 25 citing articles:

Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality
Ilenia Gatto, Emanuela Biagioni, Irene Coloretti, et al.
Intensive Care Medicine (2022) Vol. 48, Iss. 6, pp. 706-713
Open Access | Times Cited: 62
SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19
Geidy E. Serrano, Jessica E. Walker, Cécilia Tremblay, et al.
Journal of Neuropathology & Experimental Neurology (2022) Vol. 81, Iss. 9, pp. 666-695
Open Access | Times Cited: 35
Inflammatory biomarkers to predict the prognosis of acute bacterial and viral infections
Aline H. de Nooijer, Peter Pickkers, Mihai G. Netea, et al.
Journal of Critical Care (2023) Vol. 78, pp. 154360-154360
Open Access | Times Cited: 15
Immune Cell-Based versus Albumin-Based Ratios as Outcome Predictors in Critically Ill COVID-19 Patients
Snježana Zeba, Maja Šurbatović, Ivo Udovičić, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 73-90
Open Access
Monocytic HLA-DR Expression in Immune Responses of Acute Pancreatitis and COVID-19
Shiyu Liu, Wenjuan Luo, Peter Szatmary, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3246-3246
Open Access | Times Cited: 14
SARS-CoV-2 envelope protein regulates innate immune tolerance
Eric S. Geanes, Rebecca McLennan, Stephen Pierce, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109975-109975
Open Access | Times Cited: 3
Patients with SARS-CoV-2-Induced Viral Sepsis Simultaneously Show Immune Activation, Impaired Immune Function and a Procoagulatory Disease State
Andreas Limmer, Andrea Engler, Simone Kattner, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 435-435
Open Access | Times Cited: 7
Infection with SARS-CoV-2 Is Associated with Elevated Levels of IP-10, MCP-1, and IL-13 in Sepsis Patients
Tanja Eichhorn, Silke Huber, René Weiss, et al.
Diagnostics (2023) Vol. 13, Iss. 6, pp. 1069-1069
Open Access | Times Cited: 7
Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot
Evan L. Barrios, Monty B. Mazer, Patrick W. McGonagill, et al.
JCI Insight (2023) Vol. 9, Iss. 2
Open Access | Times Cited: 6
A disturbed balance between blood complement protective factors (FH, ApoE) and common pathway effectors (C5a, TCC) in acute COVID-19 and during convalesce
Krzysztof Laudański, Tony Okeke, Kumal Siddiq, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
ICU-Acquired Colonization and Infection Related to Multidrug-Resistant Bacteria in COVID-19 Patients: A Narrative Review
Alexandre Gaudet, Louis Kreitmann, Saad Nseir
Antibiotics (2023) Vol. 12, Iss. 9, pp. 1464-1464
Open Access | Times Cited: 5
Epigenetics at the Intersection of COVID-19 Risk and Environmental Chemical Exposures
Catherine M. Bulka, Adam E. Enggasser, Rebecca C. Fry
Current Environmental Health Reports (2022) Vol. 9, Iss. 3, pp. 477-489
Open Access | Times Cited: 9
From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?
Goran Rondović, Dragan Djordjević, Ivo Udovičić, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2620-2620
Open Access | Times Cited: 8
Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection
Jane Shaw, Stephanus T. Malherbe, Gerhard Walzl, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Adverse Long-Term Outcomes and an Immune Suppressed Endotype in Sepsis Patients with Reduced Interferon-γ ELISpot: A Multicenter, Prospective Observational Study
Evan A. Barrios, Monty B. Mazer, Patrick W. McGonagill, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Expression of Tissue Factor and Platelet/Leukocyte Markers on Extracellular Vesicles Reflect Platelet–Leukocyte Interaction in Severe COVID-19
Tanja Eichhorn, René Weiss, Silke Huber, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16886-16886
Open Access | Times Cited: 4
A novel virotherapy encoding human interleukin-7 improves ex vivo T lymphocyte functions in immunosuppressed patients with septic shock and critically ill COVID-19
Morgane Crausaz, Guillaume Monneret, Filippo Conti, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
IL-6, IL-10, sFas, granulysin and indicators of intestinal permeability as early biomarkers for a fatal outcome in COVID-19
Alejandro Hernández-Solís, Azmavet M. Güemes-González, Ximena Ruiz-Gómez, et al.
Immunobiology (2022) Vol. 227, Iss. 6, pp. 152288-152288
Open Access | Times Cited: 5
The function of myeloid-derived suppressor cells in COVID-19 lymphopenia
Taosan Li, Fang Zheng, Fanjun Cheng
International Immunopharmacology (2022) Vol. 112, pp. 109277-109277
Open Access | Times Cited: 4
Specific and Non-specific Aspects and Future Challenges of ICU Care Among COVID-19 Patients with Obesity: A Narrative Review
Alexandra Beurton, Emma J. Kooistra, Audrey De Jong, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 3, pp. 545-563
Closed Access
Determining potential immunomodulatory drug efficacy in sepsis using ELISpot
Andrew H. Walton, MB Mazer, KE Remy, et al.
(2024)
Closed Access
Surviving septic patients endotyped with a functional assay demonstrate active immune responses
Adam D. Price, Ellen R. Becker, Evan L. Barrios, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Immunological Signatures in Blood and Urine in 80 Individuals Hospitalized during the Initial Phase of COVID-19 Pandemic with Quantified Nicotine Exposure
Krzysztof Laudański, Mohamed A. Mahmoud, Ahmed Sayed, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3714-3714
Open Access
Expression of Tissue Factor and Platelet/Leukocyte Markers on Extracellular Vesicles Reflect Platelet-Leukocyte Interaction in Severe COVID-19
Tanja Eichhorn, René Weiss, Silke Huber, et al.
(2023)
Open Access | Times Cited: 1
Neutrophilic Myeloid-Derived Suppressor Cells and Severity in SARS-CoV-2 Infection
Mona A Omar, Rabab El Hawary, Alia Eldash, et al.
Laboratory Medicine (2023) Vol. 55, Iss. 2, pp. 153-161
Closed Access
Page 1

Scroll to top